Novonesis (Novozymes) B/ DK0060336014 /
13/05/2024 16:59:45 | Var. +1.95 | Volume | Denaro16:59:45 | Lettera16:59:45 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
419.35DKK | +0.47% | 376,467 Fatturato: 82.4 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 116.93 bill.DKK | 1.43% | 31.57 |
GlobeNewswire
22:10
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of ...
GlobeNewswire
22:05
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Financial Results
GlobeNewswire
22:05
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
GlobeNewswire
22:05
Kandi Technologies to Report First Quarter 2024 Financial Results and Hold a Conference Call on May ...
GlobeNewswire
22:05
CompoSecure Chief Product & Innovation Officer to Speak at Seamless Middle East 2024
GlobeNewswire
22:05
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
22:05
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
22:05
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
GlobeNewswire
22:05
Banzai Continues Strong Organic Growth with the Addition of Over 230 Customers in April
GlobeNewswire
22:05
180 Degree Capital Corp. Reports Net Asset Value per Share (“NAV”) of $5.16 as of March 31, 2024